Search results
Jul 24, 2020 · · Albyn Medical reported PBT of €1.7m and EBITDA of €2.4m for the year ended 30 September 2019. As at 30 September 2019, Albyn Medical had gross assets of €15.4m. · As a well-established...
Jul 24, 2020 · Creo Medical Acquires Albyn Medical For EUR24.8 Million | Financial News
Share Prices. Share Prices. Financial Diary; Commodities; Broker Ratings; UK Industry Sectors
Apr 14, 2023 · Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on the field of surgical endoscopy - Updates on its earn-out agreement related to the acquisition of Albyn Medical SL, now known as Creo Medical SL. Firm acquired Albyn in July 2020 for EUR24.8 million, plus up to EUR2.7 million based on performance targets. 90% of ...
Jul 24, 2020 · Creo Medical News Headlines. CREO Share News. Financial News Articles for Creo Medical Group Plc Ord Gbp0.001 updated throughout the day.
Apr 18, 2023 · Creo Medical has announced that it has acquired the remaining 5% stake in Albyn Medical (for €1.2m), a subsidiary that is Creo’s primary revenue contributor (c €20m in FY22 sales, per our estimates). The payout also included a previously agreed €1m earnout payment.
Aug 3, 2020 · Creo Medical, a UK-based developer of endoscopic microwave and radiofrequency ablation technologies, is acquiring Albyn Medical, a Spain-based manufacturer of branded and third-party gastroenterology, urology and endoscopy products including biopsy forceps, snares, catheters, tubes and valves.
